Effects of gc-macrophage activating factor in human neurons; implications for treatment of chronic fatigue syndrome

American Journal of Immunology

Volumn 9, Issue 4, 2013, Pages 120-129

  Smith, Rodney ^a   Thyer, Lynda ^a   Ward, Emma ^a   Meacci, Elisabetta ^b   Branca, Jacopo J V ^b   Morucci, Gabriele ^b   Gulisano, Massimo ^b   Ruggiero, Marco ^b   Pacini, Alessandra ^b   Paternostro, Ferdinando ^b   Mannelli Lorenzo, Di Cesare ^c   Noakes, David J ^d   Pacini, Stefania ^b  

^a Macro Innovations Ltd   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Immuno Biotech Ltd   (United Kingdom)

Author keywords

Chronic fatigue syndrome; GcMAF; Immunotherapy; Macrophage activating factor; Vitamin D

Indexed keywords

IODOACETIC ACID; MACROPHAGE ACTIVATING FACTOR; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAMP ASSAY; CELL DIFFERENTIATION; CELL METABOLISM; CELL VIABILITY; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; ENZYME ACTIVITY; FAR WESTERN BLOTTING; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY PAIN; MALE; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PROTEIN EXPRESSION ASSAY; RAT; SIGNAL TRANSDUCTION;

EID: 84892401286     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajisp.2013.120.129     Document Type: Article

References (42)

1. Agholme, L., T. Lindstrom, K. Kagedal, J. Marcusson and M. Hallbeck, 2010. An in vitro model for neuroscience: Differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J. Alzheimer's Dis., 20: 1069-1082. DOI: 10.3233/JAD-2010-091363
2. Bansal, A.S., A.S. Bradley, K.N. Bishop, S. Kiani-Alikhan and B. Ford, 2012. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immunity, 26: 24-31. DOI: 10.1016/j.bbi.2011.06.016
3. Booth, N.E., S. Myhill and J. McLaren-Howard, 2012. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int. J. Clin. Exp. Med., 5: 208-220.
4. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem., 72: 248-254. DOI: 10.1016/0003-2697(76)90527-3
5. Bradstreet, J.J., E. Vogelaar and L. Thyer, 2012. Initial observations of elevated alpha-nacetylgalactosaminidase activity associated with autism and observed reductions from gc proteinmacrophage activating factor injections. Autism Insights, 4: 31-38. DOI: 10.4137/AUI.S10485
6. Carruthers, B.M., M.I. van de Sande, K.L. De Meirleir, N.G. Klimas and G. Broderick et al., 2011. Myalgic encephalomyelitis: International consensus criteria. J. Internal Med., 270: 327-338. DOI: 10.1111/j.1365-2796.2011.02428.x
7. Castagna, A., R. Polati, A.M. Bossi and D. Girelli, 2012. Monocyte/macrophage proteomics: Recent findings and biomedical applications. Expert Rev. Proteom., 9: 201-215. DOI: 10.1586/epr.12.11
8. Catalano, A., N. Morabito, M. Atteritano, G. Basile and D. Cucinotta et al., 2012. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis. Calcified Tissue Int., 90: 279-285. DOI: 10.1007/s00223-012-9577-6
9. Celli, A., C. Treves, P. Nassi and M. Stio, 1999. Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SHSY5Y human neuroblastoma cells. Neurochemical Res., 24: 691-698.
10. CFS, 2011. IACFS/ME international conference summary. Acceletare CFS Research.
11. Covelli, V., M.E. Passeri, D. Leogrande, E. Jirillo and L. Amati, 2005. Drug targets in stress-related disorders. Curr. Med. Chem., 12: 1801-1809. DOI: 10.2174/0929867054367202
12. Davis, M.P. and M. Srivastava, 2003. Demographics, assessment and management of pain in the elderly. Drugs Ag., 20: 23-57. DOI: 10.2165/00002512-200320010-00003
13. De Meirleir, K.L., S.F. Khaiboullina, M. Fremont, J. Hulstaert and A.A. Rizvanov et al., 2013. Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins. Vivo, 27: 177-187.
14. Fernihough, J., C. Gentry, M. Malcangio, A. Fox and J. Rediske et al., 2004. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain, 112: 83-93. DOI: 10.1016/j.pain.2004.08.004
15. Greco, M., M.D. Mitri, F. Chiriacò, G. Leo and E. Brienza et al., 2009. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity. Cancer Lett., 283: 222-229. DOI: 10.1016/j.canlet.2009.04.001
16. Gregory, K.J., B. Zhao, D.R. Bielenberg, S. Dridi and J. Wu et al., 2010. Vitamin D binding proteinmacrophage activating factor directly inhibits proliferation, migration and uPAR expression of prostate cancer cells. PLoS One, 5: e13428-e13428. DOI: 10.1371/journal.pone.0013428
17. Harrington, M.E., 2012. Neurobiological studies of fatigue. Progress Neurobiol., 99: 93-105. DOI: 10.1016/j.pneurobio.2012.07.004
18. Inui, T., D. Kuchiike, K. Kubo, M. Mette and Y. Uto et al., 2013. Clinical experience of integrative cancer immunotherapy with GcMAF. Anticancer Res., 33: 2917-2919.
19. Ivanavicius, S.P., A.D. Ball, C.G. Heapy, F.R. Westwood and F. Murray et al., 2007. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: Increased expression of ATF-3 and pharmacological characterisation. Pain, 128: 272-282. DOI: 10.1016/j.pain.2006.12.022
20. Kume, T., Y. Kawato, F. Osakada, Y. Izumi and H. Katsuki et al., 2008. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci. Lett., 443: 199-203. DOI: 10.1016/j.neulet.2008.07.079
21. Mannelli, L.D.C., D. Bani, A. Bencini, M.L. Brandi and L. Calosi et al., 2013. Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats. Mediators Inflammat., 2013: 905360-905370. DOI: 10.1155/2013/905360
22. Meeus, M., J. Nijs, L. Hermans, D. Goubert and P. Calders, 2013. The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: Peripheral and central mechanisms as therapeutic targets? Expert Opin. Therapeutic Targets, 17: 1081-1089. DOI: 10.1517/14728222.2013.818657
23. Nagasawa, H., Y. Uto, H. Sasaki, N. Okamura and A. Murakami et al., 2005. Gc protein (vitamin Dbinding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res., 25: 3689-3695.
24. Nakou, M., G. Bertsias, I. Stagakis, M. Centola and I. Tassiulas et al., 2010. Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS One, 5: e13351-e13351. DOI: 10.1371/journal.pone.0013351
25. Pacini, S., G. Morucci, J.J.V. Branca, S. Aterini, M. Amato, et al. 2013. Effects of vitamin D3 and paricalcitol on immature cardiomyocytes: A novel role for vitamin d analogs in the prevention of cardiovascular diseases. Nutrients, 5: 2076-2092. DOI: 10.3390/nu5062076
26. Pacini, S., G. Morucci, T. Punzi, M. Gulisano and M. Ruggiero, 2011. Gc protein-derived Macrophage-Activating Factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay. Cancer Immunol. Immunotherapy, 60: 479-485. DOI: 10.1007/s00262-010-0953-7
27. Pacini, S., M.G. Fiore, S. Magherini, G. Morucci and J.J. Branca et al., 2012a. Could cadmium be responsible for some of the neurological signs and symptoms of myalgic encephalomyelitis/chronic fatigue syndrome. Med. Hypotheses, 79: 403-407. DOI: 10.1016/j.mehy.2012.06.007
28. Pacini, S., T. Punzi, G. Morucci, M. Gulisano and M. Ruggiero, 2012b. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells. Anticancer Res., 32: 45-52.
29. Puri, B.K., P.M. Jakeman, M. Agour, K.D. Gunatilake and K.A. Fernando et al., 2012. Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): A voxel-based morphometry 3 T MRI study. Br. J. Radiol., 85: e270-e273. DOI: 10.1259/bjr/93889091
30. Sun, Y.L., X.Y. Zhang, N. He, T. Sun and Y. Zhuang et al., 2012. Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells. Peptides, 38: 110-117. DOI: 10.1016/j.peptides.2012.08.019
31. Thapa, A., B.C. Vernon, K. De la Peña, G. Soliz and H.A. Moreno et al., 2013. Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide-induced toxicity. Langmuir, 29: 11713-11723. DOI: 10.1021/la4020459
32. Thyer, L., E. Ward, R. Smith, J.J.V. Branca, G. Morucci et al., 2013b. Therapeutic effects of highly purified de-glycosylated GcMAF in the immunotherapy of patients with chronic diseases. Am. J. Immunol., 9: 78-84.
33. Thyer, L., E. Ward, R. Smith, M.G. Fiore and S. Magherini et al., 2013a. A novel role for a major component of the vitamin D Axis: Vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages. Nutrients, 5: 2577-2589. DOI: 10.3390/nu5072577
34. Uchida, A., 1992. Chronic fatigue immune dysfunction syndrome. Nihon Rinsho, 50: 2625-2629.
35. Xiao, G. and L.S. Gan, 2013. Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int. J. Cell Biol., 2013: 703545. DOI: 10.1155/2013/703545
36. Xie, H.R., L.S. Hu and G.Y. Li, 2010. SH-SY5Y human neuroblastoma cell line: In vitro cell model of dopaminergic neurons in Parkinson's disease. Chinese Med. J., 123: 1086-1092. DOI: 10.3760/cma.j.issn.0366-6999
37. Yamamoto, N., H. Suyama and N. Yamamoto, 2008b. Immunotherapy for prostate cancer with gc protein-derived macrophage-activating factor, GcMAF. Translat. Oncol., 1: 65-72. DOI: 10.1593/tlo.08106
38. Yamamoto, N., H. Suyama, H. Nakazato, N. Yamamoto and Y. Koga, 2008c. Immunotherapy of metastatic colorectal cancer with vitamin D-binding proteinderived macrophage-activating factor, GcMAF. Cancer Immunol. Immunotherapy, 57: 1007-1016. DOI: 10.1007/s00262-007-0431-z
39. Yamamoto, N., H. Suyama, N. Yamamoto and N. Ushijima, 2008a. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived Macrophage Activating Factor (GcMAF). Int. J. Cancer, 122: 461-467. DOI: 10.1002/ijc.23107
40. Yamamoto, N., N. Ushijima and Y. Koga, 2009. Immunotherapy of HIV-infected patients with Gc protein-derived Macrophage Activating Factor (GcMAF). J. Med. Virol., 81: 16-26. DOI: 10.1002/jmv.21376
41. Yamamoto, N., V.R. Naraparaju, M. Moore and L.H. Brent, 1997. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol., 82: 290-298. DOI: 10.1006/clin.1996.4320
42. Zikopoulos, B. and H. Barbas, 2013. Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum. Neurosci., 7: 609-609. DOI: 10.3389/fnhum.2013.00609